Results 131 to 140 of about 49,244 (195)

Measles: A Narrative Review of Current Therapeutic Options and Implications for the Future. [PDF]

Viruses
Papanikolopoulou A, Tseliou I, Maltezou HC.   +2 more
europepmc   +1 more source

A porcine model of chronic hepatitis E virus (HEV) infection identifies male reproductive glands as sites of viral persistence. [PDF]

Virulence
Yadav KK, Boley PA, Laocharoensuk T, Khatiwada S, Lee CM, Bhandari M, Hanson J, Kenney SP.   +7 more
europepmc   +1 more source

The effectiveness of Kanggan granules in treating hand, foot and mouth disease in children: a meta-analysis. [PDF]

Front Pediatr
Zhu Z.
europepmc   +1 more source

Reduction of immunosuppressants fails to clear hepatitis E virus infection in a heart transplant recipient. [PDF]

IDCases
Chen Z, Niu W, Li G, Chen X, Chen S, Zhang K, Fang M, Wang Y, Fu L, Zheng Z, Xia N.   +10 more
europepmc   +1 more source

Case Report: Allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia and hepatitis E. [PDF]

Front Oncol
Lepek J, Lugnier C, von Lilienfeld-Toal M, Witkowsi L, Götze O, Canbay A, Schroers R, Mika T.   +7 more
europepmc   +1 more source

Hantaviral therapeutics: life cycle targets and chemotherapeutic interventions. [PDF]

Front Cell Infect Microbiol
Kocabiyik DZ, de Araujo J, Durigon EL, Wrenger C.   +3 more
europepmc   +1 more source

Erlotinib in a once-daily high-dose oral regimen could mitigate Chikungunya virus titer in mice. [PDF]

PLoS One
Orji CN, Loeanurit N, Sroithongmoon A, Wacharachaisurapol N, Jumroen Y, Eiamart W, Wittayalertpanya S, Chaijamorn W, Sriboonruang T, Vamananda J, Khotavivattana T, Boonyasuppayakorn S.   +11 more
europepmc   +1 more source

Punicalin targets RSV glycoprotein and fusion protein at non-overlapping sites to prevent viral escape. [PDF]

Cell Rep Med
Xiong Y, Ming J, Zhang Z, Zhang J, Zhou X, Cao B, Li G, Zhu Y, Yang Z, Song J, Wang Z, Chen M, Tao K, Kang Y, Ji J.   +14 more
europepmc   +1 more source

Cost Effectiveness of Peginterferon alpha-2a Plus Ribavirin versus Interferon alpha-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

Introduction: In adults with previously untreated chronic hepatitis C (CHC), the combination of peginterferon alpha-2a plus ribavirin produces a higher rate of sustained virological response (SVR) than interferon alpha-2b plus ribavirin, but it is still ...
Neil Wintfeld, Antonio Craxi, Jesse Green, Alfredo Alberti, Claudio De Carli, Kavita K. Patel, Giovanni Giuliani, Sean D. Sullivan   +7 more
core  

Elbasvir Inhibits Hepatitis E Virus Internalization and, in Combination with Ribavirin, Achieves Sustained Viral Suppression In Vitro. [PDF]

Pathogens
Primadharsini PP, Nagashima S, Takahashi M, Murata K, Okamoto H.   +4 more
europepmc   +1 more source